Alecnib 150 mg Capsule

Brand Name: Alecnib

Molecule: Alectinib

Strength: 150 mg

Quantity: 56 Capsules

Form: Capsule

Packaging Type: Bottle

Manufacturer/Marketed By: Everest Pharma

Country of Origin: Bangladesh

Description

Alecnib Alectinib 150 mg Capsule is a targeted cancer medicine used to treat ALK-positive metastatic non-small cell lung cancer (NSCLC). It helps slow tumor growth and spread under oncologist supervision.

Benefits

Specifically targets ALK-driven lung cancer
Helps slow tumor growth and metastasis
Proven improvement in progression-free survival
Effective against brain metastases
Convenient oral dosing for long-term therapy

Indications and Usage

Alecnib Alectinib 150 mg Capsule is indicated for:

ALK-positive metastatic non-small cell lung cancer (NSCLC)
First-line treatment or after progression on previous ALK therapy

Diagnosis must be confirmed by ALK-testing, and treatment supervised by an oncologist.

How it Works

Alectinib blocks the activity of ALK (Anaplastic Lymphoma Kinase) — an abnormal protein that drives cancer growth in certain lung cancers. By inhibiting ALK signaling, it prevents cancer cells from multiplying and spreading.

Dosage & Administration

Usual adult dose: 600 mg per day (150 mg capsules × 4), divided into two doses
Take with food, at the same times daily
Swallow capsules whole—do not crush or open
Do not stop or change dose without medical guidance
Requires routine liver, kidney, heart rate, and blood tests

Use only under oncologist supervision.

Side Effects

Common side effects:

Constipation
Fatigue
Swelling in hands or feet
Muscle pain
Rash
Low red blood cell count

Serious side effects (seek urgent care):

Liver toxicity
Lung inflammation (pneumonitis)
Severe muscle damage (high CPK levels)
Slow heart rate
Severe anemia

Warning and Precaution

Not recommended during pregnancy or breastfeeding
Monitor liver function, CPK levels, heart rhythm, and lung symptoms
Use caution in patients with kidney or liver disease
Avoid driving if experiencing dizziness or vision changes
Inform doctor about all medications to prevent interactions
Report breathing difficulty, severe fatigue, jaundice, or muscle pain immediately